Tharimmune, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
THAR on Nasdaq
Location
1200 Route 22 East, Bridgewater, NJ

Insiders trading volume in the past year

Tharimmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Highpoint Pharmaceuticals LLC 10%+ Owner $489K Jan 11, 2022
Kufe LLC 10%+ Owner $408K Jan 11, 2022
Surender Kharbanda 10%+ Owner $363K Jan 11, 2022
Varinder Kaur 10%+ Owner $328K Jan 11, 2022
Sandeep Laumas 10%+ Owner $320K Jan 11, 2022
Randy Milby CEO, Director $27.2K +$29.8K Oct 8, 2024
Sireesh Appajosyula Chief Operating Officer, Director $21.8K +$29.4K Nov 13, 2024
Thomas Hess Chief Financial Officer Jan 11, 2022
Leonard L. Mazur Director Aug 9, 2024
Lynne Bui Director Aug 9, 2024
Kelly Anderson Director Aug 9, 2024

Recent Insider Transactions by Companies or Individuals for Tharimmune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.